Old Web
English
Sign In
Acemap
>
Paper
>
First Line Therapy in Multiple Myeloma: VAD vs Bortezomib -Dexamethasone
First Line Therapy in Multiple Myeloma: VAD vs Bortezomib -Dexamethasone
2019
Ema-Cristina Borsi
Adina Ioana Bucur
Cristina Potre Oncu
Ovidiu Potre Oncu
Bianca Cerbu
Dan Costachescu
Ioana Ionita
Constantin Luca
Hortensia Ionita
Keywords:
Chemistry
Cancer research
Multiple myeloma
Organic chemistry
first line therapy
Bortezomib/dexamethasone
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]